434 related articles for article (PubMed ID: 25924699)
1. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
[TBL] [Abstract][Full Text] [Related]
2. Formulation and characterization of polyester/polycarbonate nanoparticles for delivery of a novel microtubule destabilizing agent.
Mundra V; Lu Y; Danquah M; Li W; Miller DD; Mahato RI
Pharm Res; 2012 Nov; 29(11):3064-74. PubMed ID: 23054088
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment.
Bariwal J; Kumar V; Chen H; Bhattarai RS; Peng Y; Li W; Mahato RI
J Control Release; 2019 Sep; 309():231-243. PubMed ID: 31330213
[TBL] [Abstract][Full Text] [Related]
4. Polymer conjugate of a microtubule destabilizer inhibits lung metastatic melanoma.
Yang R; Mondal G; Ness RA; Arnst K; Mundra V; Miller DD; Li W; Mahato RI
J Control Release; 2017 Mar; 249():32-41. PubMed ID: 28130039
[TBL] [Abstract][Full Text] [Related]
5. Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma.
Soleimani AH; Garg SM; Paiva IM; Vakili MR; Alshareef A; Huang YH; Molavi O; Lai R; Lavasanifar A
Drug Deliv Transl Res; 2017 Aug; 7(4):571-581. PubMed ID: 28290050
[TBL] [Abstract][Full Text] [Related]
6. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
Athawale RB; Jain DS; Singh KK; Gude RP
Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
[TBL] [Abstract][Full Text] [Related]
7. Preparation of caffeic acid phenethyl ester-incorporated nanoparticles and their biological activity.
Lee HY; Jeong YI; Kim EJ; Lee KD; Choi SH; Kim YJ; Kim DH; Choi KC
J Pharm Sci; 2015 Jan; 104(1):144-54. PubMed ID: 25417897
[TBL] [Abstract][Full Text] [Related]
8. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
[TBL] [Abstract][Full Text] [Related]
10. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
11. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
12. A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance.
Arnst KE; Wang Y; Hwang DJ; Xue Y; Costello T; Hamilton D; Chen Q; Yang J; Park F; Dalton JT; Miller DD; Li W
Cancer Res; 2018 Jan; 78(1):265-277. PubMed ID: 29180476
[TBL] [Abstract][Full Text] [Related]
13. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
[TBL] [Abstract][Full Text] [Related]
14. Superior antimetastatic effect of pemetrexed-loaded gelatinase-responsive nanoparticles in a mouse metastasis model.
Lu N; Liu Q; Li R; Xie L; Shen J; Guan W; Qian X; Yu L; Ding Y; Jiang X; Liu B
Anticancer Drugs; 2012 Nov; 23(10):1078-88. PubMed ID: 22797177
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-loaded biodegradable polymeric micelles for lymphoma therapy.
Wang MY; Qu Y; Hu DR; Chen LJ; Shi K; Jia YP; Yi YY; Wei Q; Niu T; Qian ZY
Int J Pharm; 2019 Feb; 557():74-85. PubMed ID: 30557680
[TBL] [Abstract][Full Text] [Related]
16. Stealth and non-stealth nanocapsules containing camptothecin: in-vitro and in-vivo activity on B16-F10 melanoma.
Loch-Neckel G; Nemen D; Puhl AC; Fernandes D; Stimamiglio MA; Alvarez Silva M; Hangai M; Santos Silva MC; Lemos-Senna E
J Pharm Pharmacol; 2007 Oct; 59(10):1359-64. PubMed ID: 17910810
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
18. Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation.
Shah M; Ullah N; Choi MH; Kim MO; Yoon SC
Eur J Pharm Biopharm; 2012 Apr; 80(3):518-27. PubMed ID: 22178562
[TBL] [Abstract][Full Text] [Related]
19. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
20. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
Ahn S; Hwang DJ; Barrett CM; Yang J; Duke CB; Miller DD; Dalton JT
Cancer Chemother Pharmacol; 2011 Feb; 67(2):293-304. PubMed ID: 20383708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
